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Abstract Destruction of cyclin B is required for exit from
mitosis and meiosis. A cyclin-specific ubiquitinating system,
including cyclin-selective ubiquitin carrier protein (E2-C), is
thought to be responsible for cyclin B destruction. Here we
present the cloning, sequencing and expression analysis of
goldfish, Carassius auratus, E2-C which encodes the cyclin-
selective ubiquitin carrier protein from goldfish ovary. The
cloned cDNA is 677 bp long and encodes 172 amino acids. The
deduced amino acid sequence is highly homologous to E2-C from
other species. Recombinant goldfish E2-C possesses ubiquitinat-
ing activity against cyclin B. The expression of mRNA for E2-C
was similar to that of mRNA for cyclin B, occurring at very high
level in the ovary. The similarity of the expression pattern of E2-
C and cyclin B suggests that E2-C mediates a cyclin-specific
ubiquitination.
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1. Introduction
Proteins critical to the regulation of the cell cycle (e.g. cy-
clins, cdk inhibitors, or c-mos products) are known to be
degraded by the ubiquitin pathway [1^4]. Degradation of cy-
clin B is essential for exit from M-phase [5]. The evidence that
cyclin B degradation is mediated by ubiquitin-dependent pro-
teolysis was provided by Glotzer et al. [1]. In the case of the
degradation by the ubiquitin pathway, proteins are ligated to
ubiquitin through their lysine amino acid groups, then de-
graded by the 26S proteasome [6]. A cell cycle-regulated ubiq-
uitin ligase complex, APC/cyclosome, has been characterized
biochemically in clam and Xenopus [7,8] and genetically in
yeast [9,10]. These ubiquitin ligases catalyze polyubiquitina-
tion using a specialized ubiquitin carrier protein (E2). Among
the multiple species of E2s, UBC9 protein is required for cell
cycle progression in late G2 or early M-phase [11]. UBC4
protein can ubiquitinate cyclins in Xenopus egg extracts [8].
A novel cyclin-selective UBC family member, E2-C, was re-
ported which can ubiquitinate cyclin B (13^91)/protein A fu-
sion protein in a APC/cyclosome-dependent manner [12]. The
counterparts of E2-C were identi¢ed in Xenopus [13] and hu-
man [14]. These ¢ndings suggest that the cell-cycle speci¢c
cyclin degradation occurs through a ubiquitin-dependent pro-
teolytic system.
The 26S proteasome is an essential member of the ubiqui-
tin-dependent proteolytic system in eukaryotic cells [15]. Phys-
iological functions of the 26S proteasome include the regula-
tion of the meiotic cell cycle [16]. Previously, we reported that
puri¢ed 26S proteasome digested cyclin B and this digestion
was an initial step of cyclin B degradation in ¢sh [4]. The
mechanism of cyclin B degradation after initial cleavage by
the 26S proteasome remains to be determined.
To learn more about the molecular mechanism of cyclin B
degradation, a molecular study of the ubiquitinating system in
gold¢sh has been undertaken. In this report, we describe the
cDNA cloning of the gold¢sh E2-C and the tissue speci¢c
expression pattern of the cloned gene.
2. Materials and methods
2.1. cDNA cloning of gold¢sh E2-C
A PCR fragment was ampli¢ed from gold¢sh ovary cDNA with
primers E2-C #1 (GAYAAYYTBTTYAARTGGGT) and E2-C #4
(CCAYTTYTCYTTVARRATRTC)(Y = C or T; B = G,T or C;
R = A or G; V = A,C or G). The ampli¢ed PCR fragment was sub-
cloned into pBluescript II SK(3) vector and was sequenced. The PCR
fragment was ampli¢ed using digoxigenin (DIG) DNA labeling mix-
ture (Boehringer) to use as a probe. A V ZAPII gold¢sh ovarian
cDNA library was screened using the DIG-labeled probe. A total of
3U105 plaques were blotted onto the Hybond N nylon membranes
(Amersham) and hybridized at 60‡C in hybridization solution
(5USSC, 0.5% blocking reagent (Boehringer), 0.1% N-lauroyl sarco-
sine, 0.02% SDS) with the DIG-labeled probe. Through two rounds of
hybridization the positive plaques were isolated. Plasmid DNA was
prepared by the in vivo excision protocol using the ExAssist/SOLR
system (Stratagene). DNA sequencing was performed using a 377A
DNA sequencer (Perkin Elmer ABI) with the Dye Terminator Cycle
sequencing kit (Perkin Elmer ABI).
2.2. Expression of gold¢sh E2-C in bacteria
The full-length ORF of gold¢sh E2-C was ampli¢ed by PCR with
primers designed to produce a NdeI and XhoI site at the 5P and 3P end,
respectively. PCR fragments were inserted into the pET21b expression
vector (Stratagene) between the NdeI and XhoI site. The recombinant
proteins were produced in Escherichia coli BL21(LysE) using methods
described previously [17] and puri¢ed by a⁄nity chromatography on a
Ni-NTA Agarose (Qiagen) column according to the manufacturer’s
instructions.
2.3. Expression of cyclin B
A PCR fragment of N-terminal deletion mutant cyclin B (cyclin B
v57), which lacks the N-terminal 57 amino acids as is cut by 26S
proteasome, was ampli¢ed by PCR with primers designed to produce
a NdeI and XhoI site at the 5P and 3P end, respectively. PCR fragments
were inserted into the pET21b expression vector (Stratagene) between
the NdeI and XhoI site. 35S-labeled cyclin B v57 was produced in
rabbit reticulocyte lysates and puri¢ed using methods described pre-
viously [4].
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2.4. Electrophoresis and immunoblotting
Electrophoresis was carried out according to the method of
Laemmli [18]. Electroblotting and immunodetection were conducted
as described previously [4].
2.5. Preparation of ubiquitinating enzymes from cytosol of gold¢sh
ovulated oocytes
Ovulated oocytes were homogenized with four volumes of 20 mM
HEPES-NaOH bu¡er, pH 7.5, containing 100 mM L-glycerophos-
phate, 15 mM MgCl2, 5 mM EGTA and 1 mM DTT and the homog-
enate was centrifuged at 100 000Ug for 1 h. The supernatant was
applied to a DEAE-cellulose column (4.5U6.3 cm) equilibrated with
20 mM Tris-HCl bu¡er, pH 7.5, containing 1 mM DTT (TD bu¡er).
The column was washed with 10 volumes of the same bu¡er and
bound materials were eluted with TD bu¡er containing 0.5 M KCl
and 20 ml fractions were collected. The £ow-through fraction was
added to saturated ammonium sulfate to 45% saturation. Precipitates
were collected by centrifugation at 10 000Ug for 10 min, then dialyzed
against TD bu¡er. This fraction possessed ubiquitin ligating activity
against cyclin B as described in clam [7] and was used as the APC/
cyclosome fraction. Fractions eluted from the DEAE-cellulose column
were pooled, diluted 10-fold with TD bu¡er and applied to a
Q-Sepharose column (1.6U10.0 cm) equilibrated with TD bu¡er. Ab-
sorbed materials were eluted with a linear gradient of KCl from 0 to
1 M and fractions of 10 ml were collected. Ubiquitin-activating en-
zyme (E1) was assessed by the activity of ubiquitin thiolester complex
formation with recombinant E2-C. Active fractions were pooled and
used as a partially puri¢ed E1 fraction from gold¢sh oocytes.
2.6. Isolation of total RNA and Northern blot analysis
Total RNA from various kinds of gold¢sh tissues was isolated
using ISOGEN (WAKO) according to the manufacturer’s instruc-
tions. Northern blot analysis of mRNA for E2-C and cyclin B was
carried out as described previously [19].
3. Results and discussion
3.1. Isolation and characterization of gold¢sh E2-C cDNA
clones
Three positive clones were isolated from 3U105 plaques of
the gold¢sh ovarian cDNA library by screening with PCR-
probe. The cDNA clones all contained an insert of 0.7 kb
long. Further analysis revealed that these three clones were
identical. The cDNA was sequenced in its entirety (Fig. 1).
The clone encodes a protein of 172 amino acid residues with a
predicted molecular mass of 18 877 Da. Comparison of the
amino acid sequence revealed that this molecule is highly ho-
mologous to the E2-C of clam (60%), frog (80%) and human
(76%) [12^14] (Fig. 2). The sequence of gold¢sh E2-C contains
a cysteine residue which may be used for thiolester formation
with ubiquitin. The homology of this clone to the other ubiq-
uitin carrier proteins is under 30%, which further suggests this
gold¢sh cDNA encodes a E2-C. Recombinant protein from
the cDNA formed a thiolester complex with ubiquitin in an
E1-dependent manner (Fig. 3A). Furthermore, the recombi-
nant E2-C can ubiquitinate cyclin B in a APC/cyclosome-de-
pendent manner (Fig. 3B). Thus, we concluded that the
cDNA isolated in this study encodes the gold¢sh E2-C.
3.2. Gene expression of gold¢sh E2-C in various tissues
Using the gold¢sh E2-C cRNA probe, Northern blot anal-
ysis of various tissues revealed a major band of V0.7 kb (Fig.
4A). The intensities of the signals di¡ered signi¢cantly de-
pending on the organs. Ovary showed relatively strong signal.
Testis showed moderate signal. In other organs, signals were
quite low under the assay conditions. We also analyzed
mRNA levels of cyclin B (Fig. 4B). The expression patterns
showed a clear relationship between E2-C and cyclin B. The
similarity of the expression pattern of mRNAs supports the
notion that E2-C mediates a cyclin B-speci¢c ubiquitination.
Previously, we hypothesized that restricted digestion of cy-
clin B by 26S proteasome is an initial step in cyclin B degra-
dation in a study using puri¢ed 26S proteasome and cyclin B
[4]. In the present study, we identi¢ed a cyclin-selective ubiq-
Fig. 1. Nucleotide and amino acid sequences of gold¢sh E2-C. The
upper letters correspond to the nucleotide sequence. The lower let-
ters represent the amino acid sequence. The numbers refer to the
nucleotide positions at the end of each line. The GenBank accession
number for this sequence is AB022024.
Fig. 2. Comparison of the amino acid sequences for the gold¢sh, clam, frog and human E2-C. Conserved residues are boxed. The cysteine resi-
due responsible for ubiquitin thiolester complex formation is indicated with an asterisk. The numbers refer to the amino acid position at the
end of each line.
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uitin carrier protein and demonstrated in vitro the presence of
a ubiquitinating system in gold¢sh oocytes. The reconstruc-
tion system for these ubiquitinating enzymes, therefore, makes
it feasible to elucidate the molecular mechanism of cyclin B
degradation.
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Fig. 3. Activities of E. coli-produced gold¢sh E2-C. A: Thiolester
complex formation of recombinant gold¢sh E2-C with ubiquitin.
Puri¢ed recombinant gold¢sh E2-C (0.1 mg/ml) was incubated with
ubiquitin-activating enzyme (E1) fraction (10 Wg/ml) and/or ubiqui-
tin (1 mg/ml) as indicated. Samples were exposed to Laemmli’s SDS
sample bu¡er after incubation for 60 min at 30‡C and analyzed by
Western blotting. Blots were immunostained by an anti-PentaWHis-
tidine monoclonal antibody (QIAGEN). The position to which the
complex of ubiquitin and gold¢sh E2-C migrated is indicated as E2-
C-Ub. B: Ubiquitination of cyclin B. 35S-labeled gold¢sh cyclin B
v57 was produced in reticulocyte lysates and puri¢ed as described
[4]. Puri¢ed recombinant cyclin B v57 was incubated in a mixture
of E1 and APC/cyclosome fractions in the presence (+) or absence
(3) of recombinant E2-C. Samples were exposed to Laemmli’s SDS
sample bu¡er after incubation for 90 min at 30‡C. Ubiquitinated cy-
clin B was detected by autoradiography on Imaging plates (Fuji
Film). The position to which the major part of ubiquitinated cyclin
B migrated is indicated with an asterisk. Molecular masses of stand-
ard proteins are indicated at the left.
Fig. 4. Tissue distribution of mRNA for gold¢sh E2-C. Northern
blot analysis of E2-C (A) and cyclin B (B). Twenty microgram of
total RNAs from various organs (Br, brain; Ey, eye; Gi, gill ; He,
heart; Hp, hepatopancreous; In, intestine; Ki, kidney; Mu, muscle;
Sp, spleen; Ov, ovary; Te, testis) were used. Ribosomal RNAs were
detected by staining with ethidium bromide (C).
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